ATCC and the Broad Institute report the development of engineered isogenic cancer models designed to replicate resistance to targeted therapies, beginning with osimertinib, the latest-generation ...
Researchers at University of California San Diego have developed a new artificial intelligence (AI) model that can translate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results